CSK9 inhibitors and cardiovascular outcomes – Represented in New England Journal of Medicine by the FOURIER and SPIRE trials.
27 August 2017 (16:30 - 16:52)
Organised by:
Slides
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
3 More presentations in this session
Doctor J. Wykrzykowska (Groningen, NL)
Professor L. Kober (Copenhagen, DK)
Access the full session
The Event
ESC Congress 2017
27 August 2017
16:30 CET
You may be interested in
Congress Presentation
ESC TV Today
Congress Presentation
